Quotient Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$841K Buy
2,323
+23
+1% +$7.87K 0.02% 144
2026
Q1
$809K Buy
2,300
+177
+8% +$63.1K 0.02% 136
2025
Q4
$695K Buy
2,123
+4
+0.2% +$1.27K 0.02% 155
2025
Q3
$598K Sell
2,119
-6
-0.3% -$1.74K 0.02% 168
2025
Q2
$593K Sell
2,125
-91
-4% -$25.8K 0.02% 162
2025
Q1
$690K Buy
2,216
+405
+22% +$120K 0.02% 143
2024
Q4
$472K Sell
1,811
-113
-6% -$33.5K 0.02% 181
2024
Q3
$620K Buy
1,924
+13
+0.7% +$4.25K 0.02% 155
2024
Q2
$597K Buy
1,911
+264
+16% +$77.6K 0.02% 156
2024
Q1
$468K Buy
1,647
+160
+11% +$46.8K 0.02% 179
2023
Q4
$428K Buy
+1,487
New +$405K 0.02% 189

Other funds holding AMGN

Quotient Wealth Partners's AMGN Position: Q2 2026 in Review

Quotient Wealth Partners increased its Amgen (AMGN) stake by 1% in Q2 2026, buying an estimated $7.87K and bringing the position to 2,323 shares worth $841K. The position accounts for 0.02% of the portfolio, ranked #144.

Quotient Wealth Partners first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Quotient Wealth Partners held 2,323 shares of Amgen worth $841K as of Q2 2026.
  • Quotient Wealth Partners bought 23 Amgen shares in Q2 2026, an estimated $7.87K.
  • Amgen made up 0.02% of Quotient Wealth Partners's portfolio in Q2 2026, its #144 holding.
  • Quotient Wealth Partners first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Quotient Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.